Myriad Genetics
Myriad myChoice CDx is an FDA-approved companion diagnostic for identifying homologous recombination deficiency (HRD) status.
Get started with Myriad Genetics
How to get started
Upload your records
Pathology, genomics, imaging — whatever you have. We extract the clinical details automatically so nothing gets retyped. Upload records →
Share with Myriad Genetics
We package your records into a secure, HIPAA-compliant bundle and pre-fill the intake. You review and sign — that's it. Share records →
Myriad Genetics reaches out
Their team confirms next steps directly with you — testing, scheduling, consultation, or enrollment.
About this service
Myriad myChoice CDx is an FDA-approved companion diagnostic for identifying homologous recombination deficiency (HRD) status.
HRD Testing (myChoice CDx)
Coverage, insurance & cost
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Myriad Genetics handles billing.
Accepted
Available
Required
In-network carriers
Ask about this service
Answers grounded in Myriad's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Who this is for
Cancer types served
Common questions in this category
Based on what other patients have asked.
When is a pet/ct scan advised for a new breast cancer diagnosis
Breast CancerDoes the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.
Is the CHEK2 mutation related to prostate cancer
What lifestyle changes are recommended for Prostate - Early Stage patients
Prostate - Early StageWhat should I ask my oncologist after a new diagnosis
Should I get germline testing for BRCA and ATM mutations
Prostate CancerAlso consider
Other providers in similar categories.
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Invitae
2 offeringsInvitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
Guardant Health
Guardant360 is a comprehensive liquid biopsy test that analyzes ctDNA to identify genomic alterations and guide treatment decisions.
Get personalized guidance for your case
This page is general information. Upload your records for analysis specific to YOUR diagnosis.